坦洛新联合热淋清颗粒治疗绝经后女性尿道综合征的临床疗效分析  

Clinical efficacy of tamsulosin hydrochloride combined with relinqing granule in the treatment of urethral syndrome in postmenopausal females

作　　者：马富俊[1] 刘晓昀[1] 

机构地区：[1]山东省胜利油田中心医院泌尿外科,山东东营257034

出　　处：《现代预防医学》2014年第2期233-234,共2页Modern Preventive Medicine

摘　　要：目的探讨盐酸坦洛新联合热淋清颗粒治疗绝经后女性尿道综合征的临床疗效。方法将80例门诊就诊的绝经后女性尿道综合征患者随机分为治疗组和对照组。治疗组口服盐酸坦洛新联合热淋清颗粒治疗,对照组单用盐酸坦洛新治疗。两组均随访12周,分别于治疗前和治疗后观察膀胱残余尿量变化,并评定临床疗效。结果随访12周后,治疗组膀胱残余尿量明显少于对照组(t=3.51,P<0.05),治疗组的有效率显著高于对照组(χ2=4.32,P<0.05)。结论盐酸坦洛新联合热淋清颗粒能明显改善绝经后女性尿道综合征患者症状,疗效满意。Objective The study was conducted in order to evaluate the clinical therapeutic effects of tamsulosin hydrochloride combined with Relinqing granule for postmenopausal female urethral syndrome. Methods Eighty patients were randomly divided into two groups, the treatment group and the control group. Forty patients in the treatment group were given tamsulosin hydrochloride in addition to Relinqing granule and the other 40 patients in the control group were treated with tamsulosin hydrochloride for 12 weeks. After 12 weeks, patients in two groups were evaluated, the residual urine volumes were recorded and clinical efficacy assess- ments were conducted. Results Twelve weeks after the termination of treatment, the residual urine volumes in patients from the treatment group were much lower than those from the contro｜ group （t=3.51, P〈0.05）, and the effective rates in the treatment group were significantly higher than those in the control group （x2=4.32, P〈0.05）. Conclusion Tamsulosin hydrochloride combined with Relinqing granule can significantly improve the prognosis and relieve the symptoms of postmenopansal female urethral syndrome.

关 键 词：绝经后女性 尿道综合征 热淋清颗粒 盐酸坦洛新 

分 类 号：R917[医药卫生—药物分析学]